1. Home
  2. AUPH vs HP Comparison

AUPH vs HP Comparison

Compare AUPH & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • HP
  • Stock Information
  • Founded
  • AUPH 1993
  • HP 1920
  • Country
  • AUPH Canada
  • HP United States
  • Employees
  • AUPH N/A
  • HP N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • HP Oil & Gas Production
  • Sector
  • AUPH Health Care
  • HP Energy
  • Exchange
  • AUPH Nasdaq
  • HP Nasdaq
  • Market Cap
  • AUPH 1.4B
  • HP 1.6B
  • IPO Year
  • AUPH 1999
  • HP N/A
  • Fundamental
  • Price
  • AUPH $12.22
  • HP $17.59
  • Analyst Decision
  • AUPH Strong Buy
  • HP Hold
  • Analyst Count
  • AUPH 4
  • HP 10
  • Target Price
  • AUPH $12.25
  • HP $21.67
  • AVG Volume (30 Days)
  • AUPH 2.8M
  • HP 2.4M
  • Earning Date
  • AUPH 07-31-2025
  • HP 08-06-2025
  • Dividend Yield
  • AUPH N/A
  • HP 5.69%
  • EPS Growth
  • AUPH N/A
  • HP N/A
  • EPS
  • AUPH 0.42
  • HP N/A
  • Revenue
  • AUPH $260,111,000.00
  • HP $3,428,058,000.00
  • Revenue This Year
  • AUPH $12.15
  • HP $36.76
  • Revenue Next Year
  • AUPH $18.34
  • HP $4.08
  • P/E Ratio
  • AUPH $29.06
  • HP N/A
  • Revenue Growth
  • AUPH 25.59
  • HP 25.92
  • 52 Week Low
  • AUPH $6.23
  • HP $14.65
  • 52 Week High
  • AUPH $12.53
  • HP $37.46
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 78.39
  • HP 56.65
  • Support Level
  • AUPH $11.18
  • HP $17.43
  • Resistance Level
  • AUPH $11.69
  • HP $18.43
  • Average True Range (ATR)
  • AUPH 0.60
  • HP 0.80
  • MACD
  • AUPH 0.12
  • HP 0.19
  • Stochastic Oscillator
  • AUPH 91.61
  • HP 74.23

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Share on Social Networks: